Work

Long-term Treatment With Elafibranor Leads to Biochemical and Symptomatic Improvements for at Least 3 Years in Patients With PBC.

Year: 2025
Type: article
Source: PubMed
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7128408203
FWCI: 0.319
Cites:
Cited by: 1
Related to: 10